UroGen Pharma Ltd.
Status: Publicly traded
Direct answer
UroGen Pharma Ltd. is publicly traded on NASDAQ under the ticker URGN.
UroGen Pharma Ltd. is a biotechnology firm dedicated to creating and marketing innovative treatments for specialized cancers and diseases affecting the urinary tract. Its proprietary technology includes RTGel, a biocompatible polymer with reverse thermal gelation properties designed to enhance the efficacy of existing medications. The company also markets Jelmyto, used in pyelocalyceal solutions. A key component of...
Can you invest in UroGen Pharma Ltd.?
Yes. UroGen Pharma Ltd. trades publicly on NASDAQ as URGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for UroGen Pharma Ltd.
Detailed equity research is provided by MarketSnap.